These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8641394)
1. Platelet-specific antibodies in transfused patients. Uhrynowska M; Zupańska B Eur J Haematol; 1996 Apr; 56(4):248-51. PubMed ID: 8641394 [TBL] [Abstract][Full Text] [Related]
2. Platelet alloantibodies in transfused patients. Kiefel V; König C; Kroll H; Santoso S Transfusion; 2001 Jun; 41(6):766-70. PubMed ID: 11399817 [TBL] [Abstract][Full Text] [Related]
3. Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic patients. Schnaidt M; Northoff H; Wernet D Transfus Med; 1996 Jun; 6(2):111-4. PubMed ID: 8809957 [TBL] [Abstract][Full Text] [Related]
4. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Novotny VM; van Doorn R; Witvliet MD; Claas FH; Brand A Blood; 1995 Apr; 85(7):1736-41. PubMed ID: 7703481 [TBL] [Abstract][Full Text] [Related]
5. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children]. Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051 [TBL] [Abstract][Full Text] [Related]
6. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients. Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715 [TBL] [Abstract][Full Text] [Related]
7. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness. Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758 [TBL] [Abstract][Full Text] [Related]
8. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675 [TBL] [Abstract][Full Text] [Related]
9. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness]. Basire A; Picard C Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423 [TBL] [Abstract][Full Text] [Related]
10. [Demonstration of platelet-specific alloantibodies in HLA-sensitized hematologic oncologic patients]. Schnaidt M; Wernet D; Mayer G; Northoff H Beitr Infusionsther Transfusionsmed; 1994; 32():240-3. PubMed ID: 9480099 [TBL] [Abstract][Full Text] [Related]
11. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test. Kurz M; Knöbl P; Kalhs P; Greinix HT; Höcker P; Panzer S Transfusion; 2001 Jun; 41(6):771-4. PubMed ID: 11399818 [TBL] [Abstract][Full Text] [Related]
12. Frozen platelet plates for platelet antibody detection and cross-match. Porretti L; Marangoni F; Rebulla P; Sirchia G Vox Sang; 1994; 67(1):52-7. PubMed ID: 7975453 [TBL] [Abstract][Full Text] [Related]
13. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies. Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262 [TBL] [Abstract][Full Text] [Related]
14. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients. Godeau B; Fromont P; Seror T; Duedari N; Bierling P Br J Haematol; 1992 Jul; 81(3):395-400. PubMed ID: 1390213 [TBL] [Abstract][Full Text] [Related]
15. The detection of platelet antibodies by simultaneous analysis of specific platelet antibodies and the monoclonal antibody-specific immobilization of platelet antigens: an interlaboratory comparison. Nguyen XD; Goebel M; Schober M; Klüter H; Panzer S Transfusion; 2010 Jul; 50(7):1429-34. PubMed ID: 20456677 [TBL] [Abstract][Full Text] [Related]
16. Three cases of platelet alloimmunisation associated with the presence of a novel platelet-specific antibody. Masters R; Taaning E Vox Sang; 1998; 75(3):242-6. PubMed ID: 9852414 [TBL] [Abstract][Full Text] [Related]
17. A study of platelet alloantibody in multiply-transfused haematology patients. Linn YC; Prakash P; Ong YW Ann Acad Med Singap; 1995 Mar; 24(2):305-11. PubMed ID: 7653976 [TBL] [Abstract][Full Text] [Related]
18. Development of quantitative monoclonal antibody-specific immobilization of platelet antigens assay for antibodies against human platelet antigen-1a, 3a, and 5b. Li RS; Ling B; Lu P Platelets; 2018 Jan; 29(1):71-75. PubMed ID: 28406722 [TBL] [Abstract][Full Text] [Related]
19. Post-transfusion purpura (PTP) associated with anti-HPA-1a, anti-HPA-2b and anti-HPA-3a antibodies. Lucas GF; Pittman SJ; Davies S; Solanki T; Brüggemann K Transfus Med; 1997 Dec; 7(4):295-9. PubMed ID: 9510928 [TBL] [Abstract][Full Text] [Related]
20. Serological screening, using three different test systems of platelet-transfused patients with hematologic-oncologic disorders. Wernet D; Schnaidt M; Mayer G; Northoff H Vox Sang; 1993; 65(2):108-13. PubMed ID: 8212664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]